Indian media criticizes Pfizer after Ivermectin success
FILE – This October 2021, photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer via AP, File)
OAN Newsroom
UPDATED 8:42 AM PT – Tuesday, November 2, 2021
A media company in India are ramping up criticism of COIVD-19 vaccine suppliers following the nation’s success at treating the virus with Ivermectin. In a recent report, Indian television channel WION claimed Pfizer is maximizing revenues by selling COVID-19 vaccines to developing nations on often predatory terms.
“What happens when vaccine manufacturers starts bullying? Governments are silenced, supplies are hoarded and profits take precedence over saving lives.”
— Palki Sharma, foreign affairs reporter – WION
The channel cited a separate report by Public Citizen that detailed Pfizer’s distribution agreements in emerging markets. WION found those contracts give up power to some government authority to Pfizer.
“Practically anything that a sovereign government owns — foreign bank accounts, foreign investments, commercial property, state-run airlines, even oil companies — Pfizer can takeover any or all of these from a government. Basically everything happens in Pfizer terms once a country decides to buy its vaccine.”
— Palki Sharma, foreign affairs reporter – WION
WION’s report went on to describe Pfizer’s actions as having long-term political, economic and social risks to developing countries.
FULL REPORT:
MORE NEWS: White House Acquiring 28M Child Vaccine Doses
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
